SEC Comment Letter 0000000000-25-002732 to CEL SCI CORP (CVM)

CEL SCI CORP
Date: March 12, 2025 · CIK: 0000725363 · Accession: 0000000000-25-002732

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 001-11889

Date

March 12, 2025

Author

Finance

Form

UPLOAD

Company

CEL SCI CORP

Letter

Re: CEL-SCI Corporation Form 10-K for Fiscal Year Ended September 30, 2024 Filed January 13, 2025 File No. 001-11889 Dear Patricia Prichep:

March 12, 2025

Patricia Prichep Chief Financial Officer CEL-SCI Corporation 8229 Boone Blvd., Suite 802 Vienna, Virginia 22182

We have completed our review of your filings. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.

Sincerely,
Division of Corporation
Finance
Office of Life Sciences

Show Raw Text

<DOCUMENT>
<TYPE>TEXT-EXTRACT
<SEQUENCE>2
<FILENAME>filename2.txt
<TEXT>
 March 12, 2025

Patricia Prichep
Chief Financial Officer
CEL-SCI Corporation
8229 Boone Blvd., Suite 802
Vienna, Virginia 22182

 Re: CEL-SCI Corporation
 Form 10-K for Fiscal Year Ended September 30, 2024
 Filed January 13, 2025
 File No. 001-11889
Dear Patricia Prichep:

 We have completed our review of your filings. We remind you that the
company and
its management are responsible for the accuracy and adequacy of their
disclosures,
notwithstanding any review, comments, action or absence of action by the staff.

 Sincerely,

 Division of Corporation
Finance
 Office of Life Sciences
</TEXT>
</DOCUMENT>

SecProbe.io